Corrected: BRIEF-ESAB outlook FY core sales growth -1.0% - +1.5%
01/05/2025 11:30
• Q1 core adjusted EBITDA USD 128 million Q1 Sales USD 678 Million Vs. IBES Estimate USD 647.5 Million outlook FY core organic growth 0-2%
Recent news on ESAB
See all newsBrief: ESAB Corp - Declares QTRLY Cash Dividend Of $0.12 Per Share
Esab Corp Reports Results For The Quarter Ended June 30: Earnings Summary
ESAB Corp beats Q2 sales estimates, raises FY core net sales growth
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation
Brief: Esab - Appoints Mitchell P. Rales As Executive Chair Effective June 10, 2026 - SEC Filing